Hims & Hers Health, Inc. (HIMS) EPS CAGR:-1.73%(TTM)
The eps cagr for Hims & Hers Health, Inc. (HIMS) is -1.73% over the latest trailing 12-month period. EPS CAGR uses precomputed diluted earnings history where available.
The eps cagr for Hims & Hers Health, Inc. (HIMS) stock is -1.73% over the past 12 months. EPS (Earnings Per Share) CAGR measures how Hims & Hers Health, Inc.'s earnings per share have grown. This is a key metric for valuation and reflects profitability on a per-share basis.
HIMS EPS CAGR Chart
Hims & Hers Health, Inc. (HIMS)
HIMS EPS CAGR History
| Year | Start EPS | End EPS | Change | % Change | CAGR |
|---|---|---|---|---|---|
| 2025 | $0.58 | $0.57 | $-0.01 | -1.72% | -1.72% |
| 2024 | $-0.11 | $0.58 | +$0.69 | +0.00% | N/A |
| 2023 | $-0.32 | $-0.11 | +$0.21 | +0.00% | N/A |
| 2022 | $-0.58 | $-0.32 | +$0.26 | +0.00% | N/A |
| 2021 | $-0.51 | $-0.58 | $-0.07 | +0.00% | N/A |
| 2020 | $-2.07 | $-0.51 | +$1.56 | +0.00% | N/A |
Quarterly EPS — QoQ & YoY
| Quarter | Value | QoQ | YoY |
|---|---|---|---|
| Q1 2026 | $-0.40 | -544.4% | -281.8% |
| Q4 2025 | $0.09 | +28.6% | -25.0% |
| Q3 2025 | $0.07 | -63.2% | -80.0% |
| Q2 2025 | $0.19 | -13.6% | +206.5% |
| Q1 2025 | $0.22 | +83.3% | +340.0% |
| Q4 2024 | $0.12 | -65.7% | +1933.9% |
| Q3 2024 | $0.35 | +464.5% | +1072.2% |
| Q2 2024 | $0.06 | +24.0% | +280.8% |
| Q1 2024 | $0.05 | +747.5% | +202.9% |
| Q4 2023 | $0.01 | +116.4% | +111.2% |
| Q3 2023 | $-0.04 | -5.0% | +60.8% |
| Q2 2023 | $-0.03 | +29.4% | +64.5% |
| Q1 2023 | $-0.05 | +8.1% | +39.4% |
| Q4 2022 | $-0.05 | +42.4% | +64.7% |
| Q3 2022 | $-0.09 | +4.9% | -15.2% |
| Q2 2022 | $-0.10 | -20.3% | -102.3% |
QoQ = change vs the prior quarter; YoY = change vs the same quarter a year earlier.
About Hims & Hers Health, Inc.
Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its user-friendly websites and mobile app, the company delivers a diverse portfolio of health and wellness solutions directly to consumers. This includes access to recurring prescription medications, alongside a wide selection of over-the-counter drugs, devices, cosmetics, and dietary supplements. Its core focus areas are general wellness, sexual health, skincare, and hair care. Specific non-prescription offerings span categories such as: Wellness: encompassing items like vitamin C, melatonin, biotin, and collagen protein supplements. Skincare: including products such as moisturizers, serums, and face washes. Sexual Health: providing essentials like condoms, climax delay sprays and wipes, vibrators, and lubricants. Hair Care: offering specialized shampoos, conditioners, scalp scrubs, and topical treatments like minoxidil. Beyond direct sales, Hims & Hers also distributes health and wellness products via wholesale partnerships. The company's headquarters are located in San Francisco, California.
- Sector
- Healthcare
- Industry
- Medical - Equipment & Services
- CEO
- Andrew Dudum